Read about how the Lupus Foundation of America is uniting communities to raise lupus awareness and support and how you can get involved to help make lupus visible. Read Full Article

Toni Braxton spoke recently about a “traumatic” heart procedure she underwent after she experienced a life-threatening lupus complication. Read Full Article Article Credit: Lupus Foundation of America | lupus.org

New research in machine learning finds four predictive lupus disease profiles. Read Full Article

JW Therapeutics has received approval from the National Medical Products Administration of China to conduct a Phase 1 / 2 clinical trial of its CAR T-cell therapy, relmacabtagene autoleucel (relma-cel), for people with moderate to severe and/or treatment-resistant lupus. CAR T-cells are genetically altered T-cells that play a role in the immune response. Scientists create…

A high-fat diet may accelerate the development of lupus, worsen lupus symptoms and increase markers of autoimmune disease in lupus-prone mice, according to new research.   READ FULL ARTICLE   Article Credit: Lupus Foundation of America | lupus.org

The drug treatment, LUPKYNIS® (voclosporin), reduced inflammation and prevented development of kidney damage in people with lupus nephritis (LN, lupus-related kidney disease) over 18 months. Those taking the medication also didn’t exhibit any signs of kidney-related toxicity. LUPKYINS® is a novel, structurally modified calcineurin inhibitor (CNI) that works in two ways – acting as an…

Congratulations to our board members, Dr. Sam Lim, Georgia State Rep. Kim Schofield and Founder Bryant Reid for being named Community Service awardees at the Phenomenal Women’s Health Annual Fundraising Tea.   (Pictured in the photo above l to r: Kim Schofield – Georgia State Representative, Teri Edmond – CEO of Lupus Foundation of America…

March 30, 2023 Research shows younger people living with lupus and those living in rural or disadvantaged areas are less likely to have a follow-up appointment with their doctor shortly after they’ve been discharged from the hospital. One quarter of people with lupus are hospitalized every year, and one-third are re-hospitalized within 30 days, underscoring…

March 27, 2023 AbbVie announced that its drug therapy upadacitinib (also known as RINVOQ®) is entering Phase 3 clinical trial for treatment of lupus. RINVOQ is already approved for the treatment of other autoimmune conditions, such as rheumatoid arthritis, psoriatic arthritis, and eczema. In the M19-130 Phase 2 trial of RINVOQ, the drug met its…

March 6, 2023   In a new study, organ damage was associated with worse cognitive performance in people with lupus. Cognitive dysfunction (CD) or “brain fog ” is a functional impairment whereby an individual exhibits deficits in attention, learning (verbal and nonverbal), memory (short-term and working), problem solving, motor (physical) function, processing speed, visual and…